ABSTRACT The M2 protein of the influenza A virus acts both as a drug-sensitive proton channel and mediates virus budding through membrane scission. The segment responsible for causing membrane curvature is an amphipathic helix in the cytoplasmic domain of the protein. Here, we use 31 P and 13 C solid-state NMR to examine M2-induced membrane curvature. M2 , which includes only the transmembrane (TM) helix, and M2(21-61), which contains an additional amphipathic helix, are studied.
INTRODUCTION
Many membrane peptides and proteins cause curvature to the phospholipid bilayer as their mechanism of action. Examples include viral fusion proteins (1-3), antimicrobial peptides (4-6), cell penetrating peptides (7) , and proteins that pinch off newly assembled viruses from host cells (8). Protein-induced membrane curvature can be examined by small-angle x-ray scattering (6,9) and electron microscopy (EM) (10,11), which, however, cannot detect the protein structure. Solid-state NMR spectroscopy is a unique tool to simultaneously investigate membrane curvature and the high-resolution structures of membrane proteins (12). 31 P chemical shifts depend sensitively on the phase and dynamics of the lipid membrane (13) . Lamellar bilayers with uniaxially mobile lipids give rise to static 31 P powder patterns with a motionally narrowed span of~45 ppm, with the maximum intensity at the low-frequency edge of the powder pattern. Lipid morphologies with isotropic symmetry, including micelles, small isotropic vesicles, and cubic phases, manifest a narrow peak at the 31 P isotropic shift of~0 ppm. The width of the isotropic peak depends on the size of the isotropic domain: the smaller the assembly, the faster the lipid reorientation over the surface of the isotropic domain, and the sharper the 31 P signal (14) . Hexagonal phases exhibit a powder pattern that is inverted from the lamellar phase powder pattern around the isotropic shift, and the chemical shift span is halved (15) . 31 P NMR has been used to study membrane curvature induced by antimicrobial peptides (16) (17) (18) (19) , fusion peptides (20) , and other membrane-active peptides (21, 22) . However, few studies have investigated protein partitioning into membrane domains with different curvatures. Knowledge of protein partitioning is important, because membrane protein conformation and dynamics can be sensitive to membrane curvature, in addition to other environmental factors (23) .
The M2 protein of influenza A viruses have been extensively studied for its drug-sensitive proton channel activity (24, 25) . M2 assembles into a tetrameric bundle that opens at low pH to conduct protons (26) . Endocytosis of the virus into the acidic endosome of the host cell opens the channel, acidifies the virion, and releases the viral ribonucleoprotein complex into the cell. The channel is inhibited by the adamantane class of antiviral drugs. Mutagenesis and electrophysiological experiments suggested the drug-binding site to lie in the transmembrane (TM) pore (27) (28) (29) . This is supported by a high-resolution x-ray crystal structure (30) of the M2 TM peptide (M2TM), which showed amantadine (Amt) electron densities in the N-terminal pore. However, a solution NMR structure of a longer M2 construct containing both the TM domain and an amphipathic cytoplasmic helix did not detect drug in the pore, but instead found drug-protein crosspeaks for residues on the C-terminal lipid-facing surface of the TM helix (31) . A subsequent solid-state NMR study revealed that this surface site results from nonspecific association of excess drugs from the membrane, whereas the pore site near residue S31 is the high-affinity binding site (32, 33) .
In addition to the proton channel function, M2 also mediates membrane scission of the newly assembled virus from the host cell (8). Electron and immunofluorescence microscopy data showed that the wild-type protein causes membrane curvature to large unilamellar vesicles, whereas amphipathic helix mutants abolish this effect in vitro and arrest virus budding in vivo (8). A peptide corresponding to the amphipathic helix reproduced the membrane budding effect of the full-length protein. The curvature-inducing effect of M2 is moderated by cholesterol. In phase-separated giant unilamellar vesicles composed of sphingomyelin (SM), polyunsaturated phosphocholine, and cholesterol, M2 resides at the boundary between the liquid-ordered and liquid-disordered phases.
In this study, we use 31 P NMR to characterize the curvatureinducing effect of M2 and 1 H relaxation and 1 H- 31 P correlation NMR to determine the location of M2 in membrane domains with different curvatures. We investigate the interactions of M2 and M2(21-61) with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) bilayers and with a cholesterolrich virus-envelope-mimetic membrane. Our data reveal the effect of membrane curvature on the conformation and drug-binding capability of the TM domain.
MATERIALS AND METHODS

Membrane sample preparation
M2 and M2(21-61) were synthesized using Fmoc chemistry by PrimmBiotech (Cambridge, MA) and purified to >95% purity. M2 spans only the TM domain, whereas M2(21-61) contains both the TM and amphipathic helices. Both peptides were 13 C, 15 N-labeled at V27, S31, G34, and D44.
DMPC bilayers and a mixed membrane (VM) mimicking the virus envelope lipid composition were used to reconstitute the peptides. The VM membrane is composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine, egg SM with predominantly 16:0 acyl chains, and cholesterol at a mole ratio of 21:21:28:30%. The lipids were codissolved in chloroform and methanol, dried under a stream of nitrogen, redissolved in cyclohexane, and lyophilized to obtain a homogeneous dry powder. The powder was suspended in pH 7.5 phosphate buffer (10 mM Na 2 HPO 4 /NaH 2 PO 4 , 1 mM EDTA, 0.1 mM NaN 3 ) and freezethawed six times to produce a uniform suspension. The peptides were solubilized in octylglucoside solution and incubated with the lipid vesicle solution at room temperature overnight, followed by dialysis for 3 days at 4 C (34).
1
H solution NMR spectra confirmed the quantitative removal of octylglucoside from the membrane at the end of the dialysis (Table S1 in the Supporting Material). No freeze-thawing was applied after dialysis, to prevent formation of small isotropic vesicles unrelated to the effect of M2. The proteoliposomes were centrifuged at 150,000 Â g for 4 h to give membrane pellets with~40 wt% hydration, which were packed into 4 mm magic-angle-spinning (MAS) rotors for NMR experiments. The peptide/lipid molar ratio was 1:8 for M2 and 1:15 for M2(21-61), both of which correspond to mass ratios of~1:2. Many samples contain Amt at 5:1 drug/ tetramer mole ratio, which corresponds to 2.0-3.8% of the lipid mass (see the Supporting Material), to monitor drug dynamics in separate studies (33) .
As controls, peptide-free DMPC and VM lamellar membranes were prepared by freeze-thawing the vesicle suspension three times for DMPC and eight times for VM membranes. Small isotropic DMPC vesicles were prepared by 10 cycles of freeze-thawing followed by 40 min of sonication. 
RESULTS
M2(21-61) causes high-curvature isotropic membrane domains
To investigate the curvature-inducing effect of M2, we measured the static 31 P spectra of DMPC and VM membranes without and with peptides ( Fig. 1 ). All spectra show a 43-48 ppm wide powder pattern with a uniaxial lineshape, as expected for liquid-crystalline lamellar bilayers. In addition, several samples exhibit a significant isotropic peak near 0 ppm. All membranes containing M2(21-61) show this isotropic peak (bottom row), whereas M2(22-46) does not cause the isotropic peak to the VM membrane and only a small isotropic peak to the DMPC membrane (middle row). The isotropic linewidth varies from 6.0 ppm for the M2(21-61)-DMPC sample to 2.2 ppm for the M2(21-61)-VM sample. For control samples without the peptide (top row), the DMPC bilayer does not show any isotropic peak, consistent with the absence of intrinsic curvature strain of phosphocholine, whereas the VM membrane shows a strong isotropic peak when Amt is present (see Fig. 1 d) but a weak one when the drug is absent (see Fig. 1 g) .
A narrow isotropic peak in static 31 P spectra indicates the presence of lipids that undergo fast isotropic reorientation on the NMR timescale. This motion can be tumbling of small vesicles in solution, or lateral diffusion of lipids over the highly curved membrane domain. The isotropic phase can be small vesicles, cubic phases, or even micelles. Given the hydration level of~40% for our samples, fast tumbling is unlikely, thus we attribute the isotropic peak primarily to lipid lateral diffusion. Regardless of the mechanism of line narrowing, the isotropic peak indicates the presence of a high-curvature membrane domain with isotropic symmetry, distinct from the lamellar phase.
Both M2(21-61) and the drug induce the isotropic phase. In the absence of M2 and Amt, the DMPC and VM membranes exhibit no or very little isotropic peak. However, when Amt is present, the VM membrane shows a strong isotropic peak while DMPC does not ( Fig. 1, a and d) . Thus, Amt and cholesterol synergistically exert curvature strain to the membrane. Cholesterol is known to be inserted into the glycerol and acyl chain regions of the lipid bilayer (37) , thus the curvature strain is negative, as indicated by x-ray diffraction, EM, and NMR studies of various cholesterol-containing membranes (38) (39) (40) . Solid-state NMR data and molecular dynamics simulations indicate that Amt also partitions to the glycerol region of the membrane (41), thus it should enhance the negative curvature. The fact that M2 completely suppressed this isotropic phase in the VM membrane (Fig. 1 , e and h), indicates that it counters the action of Amt and cholesterol by inducing positive curvature. Independent of the effect of the drug, M2(21-61) causes membrane curvature, as shown by the drug-free VM spectrum containing the peptide (Fig. 1 i) .
Although 31 P anisotropic shift indicates the phase and morphology of the membrane, isotropic 31 P chemical shift measured under MAS indicates the chemical environment and headgroup conformation of the lipids. Fig. 2 superimposes the static and MAS spectra of DMPC and VM membranes with and without M2. For the M2(21-61)-DMPC sample, the MAS spectrum resolved two isotropic peaks (Fig. 2 a) : the þ1.9 ppm peak matches the isotropic peak in the static spectrum, whereas the À1.1 ppm peak matches the average of the three principal values of the lamellar powder pattern reported recently (32) . The different isotropic shifts indicate that the isotropic lipids adopt a different headgroup conformation from the lamellar lipids, suggesting peptide perturbation. The isotropic shift difference is not caused by membrane curvature, because a peptide-free DMPC small vesicle sample showed a À1.0 ppm isotropic shift (Fig. 2 b) , identical to the isotropic shift of the lamellar lipids.
For the M2TM-VM sample free of the isotropic phase (Fig. 2 c) , 31 P isotropic shifts of À0.90 and À0.32 ppm are observed that can be attributed to lamellar 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine, and SM lipids. In comparison, the M2(21-61)-VM sample has an additional isotropic peak at þ1.8 ppm (Fig. 2 d) , in good agreement with the þ2.1 ppm isotropic peak in the static spectrum. Thus, for both DMPC and VM membranes, the high-curvature phase caused by M2(21-61) exhibit 31 P isotropic shifts that are 2-3 ppm larger than the isotropic shift of the lamellar lipids. The resolution of the 31 P isotropic shifts between the highcurvature domain and the lamellar domain allows us to use high-sensitivity MAS experiments to determine M2 partitioning. The peptide-enriched domain should exhibit similar 1 H relaxation properties between peptide 13 C detection and lipid 31 dynamic differences between the two domains should cause further relaxation differences (see below). In the experiment, no 1 H homonuclear decoupling is applied during the spin-echo period (Fig. S1 a) , to maximize the relaxation difference between the more rigid, peptide-rich, domain, and the more mobile, peptide-poor, domain. A moderate spin diffusion time is applied to equilibrate the 1 H magnetization within each domain. Fig. 3 compares the 31 P and 13 C-detected 1 H T 2 relaxation decays for three membrane samples. The M2(21-61)-DMPC sample (Fig. 3 a) has both isotropic and lamellar phases. The 1 H T 2 decay detected from the À1.1 ppm lamellar 31 P signal is slower than the decay of the isotropic lipid peak at þ1.9 ppm: at an echo delay of 4 ms, the lamellar signal decayed to 66% while the isotropic signal decayed to 31%. The peptide 13 C-detected 1 H T 2 relaxation superimposes almost completely with the T 2 decay of the high-curvature lipid domain. Thus, M2(21-61) partitions preferentially into the high-curvature phase, experiencing the same 1 H dynamics as the isotropic lipids. All 1 H T 2 decays are double exponential, with decay constants of 0.3 and 14 ms (15% and 85%) for the lamellar lipids and 0.12 and 6 ms (40% and 60%) for the isotropic lipids (Table  S2 ). The initial fast decay is most likely due to the rigid peptide protons. The faster relaxation of the isotropic lipids is a result of both a higher percentage of the initial decay and the shorter relaxation time of the slow component. The 13 C-detected curves gave 1 H T 2 values of 0.2 and 6.1 ms, in quantitative agreement with the isotropic lipid data. The T 2 values are largely independent of the spin diffusion mixing time between 25 and 225 ms (Table S2 ), indicating that at 25 ms, the 1 H T 2 -values already report the average property of the lipids, protein, and water at equilibrium. Fig. 3 b shows the 1 H T 2 decays of the M2TM-VM membrane, which does not exhibit an isotropic phase and the peptide must therefore bind entirely to the lamellar phase. The 13 C-detected 1 H T 2 decays exhibit time constants of 0.2 ms (45%) and 3 ms (55%), similar to the 13 C data of the M2(21-61)-DMPC sample. However, the two lamellar 31 P signals now decay much faster than the lamellar signal in the M2(21-61)-DMPC sample: the decay constants are 0.45 ms (60%) and 3.5 ms (40%). Thus, the 13 C and 31 P-detected 1 H T 2 decays are similar in this purely lamellar membrane, verifying the ability of this indirectly detected 1 H T 2 experiment to report the dynamic environment of the protein and lipids. The two 31 P isotropic peaks of this mixed membrane have the same 1 H T 2 decays, confirming that 1 H T 2 relaxation is influenced by curvature-dependent lipid motion rather than by the chemical structure of the lipid headgroup. Fig. 3 c shows the 1 H T 2 relaxation of the M2(21-61)-VM sample. The 31 P MAS spectrum resolves two lamellar peaks at À0.37 and À1.0 ppm and an isotropic-lipid peak at þ1.8 ppm (Fig. 2 d) . Similar to the DMPC sample, the lamellar lipids show slower T 2 relaxation than the isotropic lipids. The 13 C-detected T 2 relaxation is even faster than that of the isotropic lipids, indicating that M2(21-61) preferentially binds to the high-curvature membrane domain.
To examine the effect of the peptide on the 31 P-detected 1 H relaxation of the lipids, we compared the T 2 decays of membranes without and with M2 (Fig. 4) . For the DMPC membrane, peptide-free isotropic lipids have similar relaxation as peptide-bound isotropic lipids (Fig. 4 a) . In comparison, peptide-free lamellar lipids have slower T 2 decay than peptide-containing lamellar lipids, indicating that the presence of M2 in the lamellar phase speeds up relaxation due to the rigid protons. The VM membrane shows the same trend: the lamellar lipids have longer T 2 relaxation times in the absence of M2 than in its presence (Fig. 4, b and c) . (Fig. 5, d and e). In the 1 H-31 P HETCOR spectrum, the same H N chemical shift shows a crosspeak with the high-curvature lipid signal (þ1.9 ppm) but not with the lamellar signal (À1.1 ppm) (Fig. 5, c, f, and g ), even though the latter is five times higher than the isotropic peak. This proves unambiguously that M2(21-61) preferentially binds the high-curvature membrane domain.
In the VM membrane, M2(21-61) also shows an H N crosspeak with the isotropic lipid (Fig. S2) . However, the sphingosine backbone of SM also contains an amide proton, which gives rise to an H N -P crosspeak even in the absence of the peptide. Thus, the H N crosspeak with the þ1.8 ppm 31 P signal cannot be definitively assigned to M2, unless SM can be ascertained to be excluded from the isotropic domain.
DISCUSSION
Electron and fluorescence microscopy data showed that M2 plays important roles in influenza virus filament formation, virus budding, and release (8,10,42). The common underlying mechanism for these functions is the ability of the protein to cause membrane curvature, which occurs in 
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Protein Binding to Curved Membrane Domainsa cholesterol-dependent manner (8). However, molecular details of this curvature induction and M2-cholesterol interaction are still scarce. The current 31 P, 1 H, and 13 C NMR data, detecting membrane morphology and peptide-lipid interactions on the 1-50 nm length scale, provide useful insight into the relationship between M2 structure and membrane curvature generation. The static 31 P NMR lineshapes show unequivocally that M2(21-61) causes an isotropic phase while M2(22-46) does not, and the curvature is higher for the cholesterol-rich VM membrane than for the DMPC membrane. The isotropic phase can in principle be small vesicles, cubic phases, or even micelles, and EM or x-ray diffraction experiments would be required to determine the morphology definitively. However, a large body of literature on cholesterol-containing membranes suggests that the cubic phase is much less likely than small vesicles under our experimental conditions. Cubic phases in phosphocholine and cholesterol-containing membranes are mostly found for polyunsaturated lipids (39, 40) under very high hydration and temperature (~60 C above the phase transition temperature), whereas our VM membranes contain saturated lipids at~40% hydration and experiments were conducted at moderate temperatures of 297-303 K. Cubic phases are usually observed in association with the inverse hexagonal phase (40) , which is absent in our samples (43) . Various cationic membrane peptides incur cubic phases when the membrane contains a high level of negative-curvature phosphatidylethanolamine lipids (6,7), but the VM membrane contains equimolar phosphatidylethanolamine and phosphatidylcholine lipids. Therefore, the high-curvature phase caused by M2(21-61) most likely corresponds to small isotropic vesicles or isotropic domains in the lamellar phase. These isotropic lipids are not completely separated from the lamellar lipids, because 2D 31 P-31 P correlation spectra show crosspeaks between the lamellar and isotropic peaks within 50 ms (Fig. S4) . A partial association of the isotropic phase with the lamellar phase is consistent with EM images showing M2-containing small vesicles budding off of large unilamellar vesicles (8).
A similar example of protein-induced membrane budding is reported for the myelin basic protein, which also causes an isotropic peak in the 31 P NMR spectra, and whose cryoelectron microscopy images show small daughter vesicles pinching off of large parent vesicles (44) .
Whereas the 31 P spectra reveal the presence of an isotropic phase, 1 (46) (47) (48) (49) , t L ¼ r 2 /6 D L is 2-6 ms for a vesicle diameter of~10 nm. Such microsecond motion is much more efficient in driving T 2 relaxation, thus causing faster T 2 decays even in the absence of the peptide (Fig. 4 a) . In addition to the lipid dynamic difference, the rigidity of the peptide also speeds up 1 H T 2 relaxation and likely accounts for the fast initial decay in the M2-containing samples. Indeed, peptide-free control membranes show a much smaller fraction of the initial decay (Fig. 4) .
Curvature induction and peptide partitioning are coupled, as they should, because M2(21-61) cannot continue to create the high-curvature lipid phase while remaining in the lamellar phase without depleting the latter completely. 31 P spectral integration ( Figs. 1 and 2) indicates that the isotropic domain accounts for 10-20% of the total lipids. Because the peptide/lipid mass ratio in the samples is 1:2, if we assume a conservative upper limit of 20% for lamellar-phase M2 that is undetected by our experiments, then the peptide should represent at least 67 wt% of the isotropic domain, which suggests that each M2(21-61) tetramer would be solvated by~14 lipid molecules. This high peptide density should significantly perturb lipid packing, thus explaining the 3-ppm 31 P isotropic shift difference between the isotropic and the lamellar lipids.
Assuming that the isotropic domain corresponds to small vesicles, we can estimate the vesicle size or radius of curvature using the static 31 P linewidths. The higher the curvature, the narrower the isotropic peak. 31 P spectral simulation as a function of vesicle diameter has been reported where motional narrowing by both vesicle tumbling and lipid lateral diffusion was considered (14) . We modify that analysis to exclude vesicle tumbling due to the moderate hydration of our samples, and consider only lateral diffusion. Using a D L range of 3-10 Â 10 À8 cm 2 /s to span the literature values for both protein-containing and protein-free membranes of varying viscosity, we find a mean diameter of~26 nm for the isotropic DMPC vesicles, which has a 6-ppm linewidth for the isotropic peak, and a diameter of~10 nm for the VM vesicles, which have a 2.2-ppm linewidth (see the Supporting Material). Future experiments using dynamic light scattering and electron microscopy will be useful to verify these size estimates. Fig. 6 depicts the different curvatures of the three types of M2-containing membranes. Isolated vesicles are assumed in these models, but the trend also applies to intralamellar isotropic domains. M2TM causes no or little curvature to DMPC and VM membranes (Fig. 6 a) , both of which support drug binding based on previous peptide-drug distance measurements and 2D correlation spectra (33, 50) . Thus, formation of drug-sensitive tetrameric TM channels Biophysical Journal 102(4) 787-794 requires low membrane curvature. In contrast, M2(21-61) causes strong curvature to the VM membrane (Fig. 6 b) , in which it does not bind drug at all (32) , and moderate curvature to the DMPC membrane (Fig. 6 c) , in which it partially binds drug. The estimated 10 nm diameter for the isotropic VM vesicles is about the minimum size of small unilamellar vesicles (51,52) before entering the realm of ultrasmall unilamellar vesicles (5-10 nm diameter) and micelles, whereas the 26-nm DMPC isotropic vesicle would correspond to two bilayers separated by a water layer. These results suggest that the high curvature of the small vesicles perturb the TM helix packing, thus abolishing drug binding. In the smallest unilamellar vesicles, the amphipathic helix (53) likely resides on the outer surface, with the N-terminus of the TM domain facing the vesicle interior, which should further reduce drug binding (Fig. 6 b) .
The strong correlation between high membrane curvature and weak drug binding also suggests the reason for the absence of pore-bound drug in the 1,2-dihexanoyl-sn-glycero-3-phosphocholine-micelle solubilized M2(18-60) (31) . The aggregation number of 1,2-dihexanoyl-sn-glycero-3-phosphocholine is 84, which gives a micelle diameter that is about twofold smaller than the 10-nm isotropic VM vesicles. In this highly curved micelle, the conformation of the TM pore should be even more perturbed than in small bilayer vesicles, thus preventing drug binding.
The curvature of the VM membrane is caused by the combined action of the amphipathic helix and cholesterol: the removal of either, by using DMPC lipids or by using M2TM, moderates or suppresses the curvature. Wild-type M2 has been shown to bind cholesterol (10,54), possibly between residues 47 and 55 of the amphipathic helix. In real virus envelopes and host plasma membranes, where the lipid distribution is spatially heterogeneous and temporally dynamic and where other viral proteins exist, M2 is thought to cluster at the boundary between the raft and nonraft domains in the former but associated with the nonraft domain in the latter (8,54). Either environment has lower cholesterol levels, thus the membrane curvature should be more moderate than observed here in the synthetic lipid mixtures, which would shift the protein conformation equilibrium toward the drug-bound state.
SUPPORTING MATERIAL
Estimation of isotropic vesicle sizes from 31P NMR linewidths, M2 and amantadine contents of the various lipid membranes, four figures, two tables, and references are available at http://www.biophysj.org/biophysj/ supplemental/S0006-3495(12)00066-5.
We thank Professor Schmidt-Rohr for useful discussions. protein mediates ESCRT-independent membrane scission. (1) . The model considers both isotropic tumbling of the vesicles and lipid reorientation induced by lateral diffusion over the curved surface of the vesicle. The correlation time of motion depends on the vesicle radius according to:
In the simulations, a value of 7.808 x 10 -4 Poise was used for , the membrane viscosity. The temperature T was set at 298 K. The lateral diffusion coefficient D L was set to 10 -7 cm 2 /s. Using these parameters, a vesicle diameter of 100 nm (r = 50 nm) has a correlation time  = 8 s, while a vesicle diameter of 30 nm (r = 15 nm) gives a  of 0.25 s. The calculated 31 P NMR spectra for these two diameters give an isotropic peak linewidth of 7.9 ppm and 1.6 ppm, respectively.
In 40% hydrated membrane samples, isotropic tumbling is much slower  t   l , thus we can ignore the first term and calculate  using lipid lateral diffusion alone,   r 2 6D L . The value of D L can be estimated from the literature. Fluorescence recovery after photobleaching (2), pulsed-field gradient and relaxation NMR experiments (3) (4) (5) indicate that a D L range of 3 -10 x 10 -8 cm 2 /s encompasses both low-viscosity lipid membranes and protein-containing or cholesterol-rich membranes. Using this range, we find that to obtain a  of 8 s, for an isotropic linewidth of 7.9 ppm, the vesicle diameter is 24-44 nm, which is reduced from 100 nm due to the lack of tumbling. To obtain an isotropic linewidth of 1.6 ppm or  of 0.25 s, the vesicle diameter ranges from 4.2 to 8.0 nm.
Interpolating these diameters for the isotropic linewidths obtained for DMPC and VM membranes, we find that the 6.0 ppm linewidth of the DMPC isotropic peak corresponds to a vesicle diameter of 18-33 nm (mean value = 26 nm), while the 2.2 ppm linewidth of the VM isotropic peak translates to a vesicle diameter of 7-13 nm (mean value = 10 nm). The latter is about the minimum diameter for a unilamellar vesicle. On the other hand, the weak isotropic peak of the M2TM-DMPC sample has a linewidth of ~11 ppm, which translates to a vesicle diameter of ~50 nm, suggesting 4-5 bilayers.
These semi-quantitative estimates support the qualitative conclusion that M2(21-61) exerts strong curvature to cholesterol-rich virus-mimetic membranes and moderate curvature to DMPC bilayers. In the smallest isotropic vesicle, M2 does not bind drug, indicating that the conformation of the TM helical bundle is perturbed by the high curvature of the membrane.
M2 and amantadine contents of the various lipid membranes
For M2-containing membranes, we used peptide : lipid molar ratios of 1:8 for M2TM and 1:15 for M2 . The lipid molar amounts do not include cholesterol for the VM membrane. Amantadine (Amt) was added at a mole ratio of 5:1 drug : tetramer. These quantities translate to very low mass content of the drug in the membranes. The Amt, M2 and M2(21-61) molecular weights are about 166, 2750, and 4720 g/mol, respectively, after taking into account the isotopic labels. The DMPC molar mass is 678 g/mol. The average molecular weight of the VM membrane, without including cholesterol, is 712 g/mol. Based on these values, the M2TM : Amt : DMPC membrane at a molar ratio of 1 : 1.25 : 8 corresponds to amantadine at 2.5 wt% of the entire proteoliposome and 3.8 wt% of the lipids. For the VM samples, the Amt mass percentage is even lower due to the higher molecular weight of the lipids. For the M2(21-61) : Amt : DMPC sample with a molar ratio of 1 : 1.25 : 15, Amt constitutes 1.4 wt% of the entire proteoliposome and 2.0 wt% of the lipids. Membrane samples without M2 but with amantadine used the same drug : lipid molar ratio as the M2-containing samples. Thus, the amantadine mass percentage is low (2.0-3.8%) in all drug-containing membrane samples, and the significant isotropic peaks observed in the static 31 P spectra cannot be attributed solely to the effects of amantadine. 
